Pillstats
Rx only · Tablet, Film Coated · Oral

Tofacitinib

Brands: Xeljanz · Tofacitinib Citrate

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1357536
US makers10 labelers
Packages41
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$25.54$51.07$76.61$102.14Jan 2026Jun 2026Jul 2026
$88.818
Latest avg · Jul 22, 2026
+0%
Since Jan 1, 2026
10
Active US suppliers
34%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.0K5.9K8.9K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.6K
Rx · 2026 Q1
533K
Units dispensed
-17%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Micro Labs Limitedunknown8SUPPLYING
Macleods Pharmaceuticals Limitedunknown6SUPPLYING
Novadoz Pharmaceuticals LLCunknown5SUPPLYING
Zydus Lifesciences Limitedunknown5SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown5SUPPLYING
Apotex Corp.unknown4SUPPLYING
Somerset Therapeutics, LLCunknown2SUPPLYING
U.S. Pharmaceuticalsunknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
Pfizer Laboratories Div Pfizer Incunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.